Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

SYN

Synthetic Biologics (SYN)

Synthetic Biologics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:SYN
DateTimeSourceHeadlineSymbolCompany
12/31/20204:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SYNSynthetic Biologics Inc
12/31/20204:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SYNSynthetic Biologics Inc
12/22/20207:00AMPR Newswire (US)Synthetic Biologics Announces Washington University School of Medicine in St. Louis IRB Approval of the SYN-004 (ribaxamase) ...AMEX:SYNSynthetic Biologics Inc
11/24/20207:00AMPR Newswire (US)Synthetic Biologics Announces Extension of Compliance Plan Period by NYSE AmericanAMEX:SYNSynthetic Biologics Inc
11/18/20206:04AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
11/17/20205:25PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
11/17/20205:25PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:SYNSynthetic Biologics Inc
11/16/20207:00AMPR Newswire (US)Synthetic Biologics Engages A.G.P./Alliance Global Partners as Advisor to Assist in Evaluating Strategic OptionsAMEX:SYNSynthetic Biologics Inc
11/12/20203:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SYNSynthetic Biologics Inc
11/12/20203:40PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:SYNSynthetic Biologics Inc
11/12/20207:00AMPR Newswire (US)Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of DirectorsAMEX:SYNSynthetic Biologics Inc
11/10/20205:01PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:SYNSynthetic Biologics Inc
11/10/20204:21PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
11/10/20204:15PMPR Newswire (US)Synthetic Biologics Reports 2020 Third Quarter Operational Highlights and Financial ResultsAMEX:SYNSynthetic Biologics Inc
11/03/20204:30PMPR Newswire (US)Synthetic Biologics to Report 2020 Third Quarter Operational Highlights and Financial Results on November 10, 2020AMEX:SYNSynthetic Biologics Inc
10/28/20205:24PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:SYNSynthetic Biologics Inc
10/02/20207:00AMPR Newswire (US)Synthetic Biologics Provides Update on Investigator-Sponsored Phase 2b Clinical Study of SYN-010 in IBS-C PatientsAMEX:SYNSynthetic Biologics Inc
09/18/20207:01AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
08/06/20204:23PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
08/06/20204:15PMPR Newswire (US)Synthetic Biologics Reports 2020 Second Quarter Operational Highlights and Financial ResultsAMEX:SYNSynthetic Biologics Inc
08/04/20205:02PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:SYNSynthetic Biologics Inc
07/30/20207:00AMPR Newswire (US)Synthetic Biologics Announces FDA Clearance of Investigational New Drug Application for SYN-020 Intestinal Alkaline Phosphata...AMEX:SYNSynthetic Biologics Inc
07/29/20204:30PMPR Newswire (US)Synthetic Biologics to Report 2020 Second Quarter Operational Highlights and Financial Results on August 6, 2020AMEX:SYNSynthetic Biologics Inc
06/30/20207:00AMPR Newswire (US)Synthetic Biologics Announces Submission of IND Application to U.S. FDA for SYN-020 Intestinal Alkaline PhosphataseAMEX:SYNSynthetic Biologics Inc
05/27/20207:00AMPR Newswire (US)Synthetic Biologics Enters into Exclusive Option to License Intellectual Property for Use of SYN-020 to Treat and Prevent Age...AMEX:SYNSynthetic Biologics Inc
05/05/20204:39PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:SYNSynthetic Biologics Inc
05/05/20204:16PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
05/05/20204:15PMPR Newswire (US)Synthetic Biologics Reports 2020 First Quarter Operational Highlights and Financial ResultsAMEX:SYNSynthetic Biologics Inc
04/28/20204:30PMPR Newswire (US)Synthetic Biologics to Report 2020 First Quarter Operational Highlights and Financial Results on May 5, 2020AMEX:SYNSynthetic Biologics Inc
02/20/20204:38PMEdgar (US Regulatory)Annual Report (10-k)AMEX:SYNSynthetic Biologics Inc
 Showing the most relevant articles for your search:AMEX:SYN

Your Recent History

Delayed Upgrade Clock